Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from KYORIN Pharmaceutical Co.,Ltd. was processed by Pulse News Wire on May 20, 2026. It represents a primary source document for Japanese Dividends sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, May 20 (Pulse News Wire) – KYORIN Pharmaceutical Co.,Ltd. (4569.T) announced a dividend of ¥37 per share. The record date is 2026-03-31. The payment will be effective 2026-06-04.
View all KYORIN Pharmaceutical Co.,Ltd. disclosures →
KYORIN Pharmaceutical Co.,Ltd. [4569.T]
TOKYO, May 20 (Pulse News Wire) – KYORIN Pharmaceutical Co.,Ltd. (4569.T) announced a dividend of ¥37 per share.
The record date is 2026-03-31. The payment will be effective 2026-06-04.
Dividend declared
Per share
¥37.00
Prior year: ¥32.00 per share+¥5.00 vs prior year
Record date
2026-03-31
Payment date
2026-06-04
Total: ¥2,151M
Source: TDNet filing · Per-share amounts in yen
🟡 Confidence: Standard AI-translated content.